Friday, October 4, 2019

Lupin launches generic immunosuppressant capsules in US

Lupin launches generic immunosuppressant capsules in US As per IQVIA MAT August 2019 data, Mycophenolate Mofetil capsules USP, 250 mg, had annual sales of around $ 53 million in the US, Lupin said.

from Moneycontrol Business News https://ift.tt/30ETMsM

No comments:

Post a Comment

Paras Defence shares soar 10% as Q2 net profit jumps 50% to Rs 14 crore

Paras Defence and Space Technologies shares surged following strong September quarter results, with net profit jumping 50% and revenue climb...